MADISON, N.J. -- Wyeth announced today that a study published in this week's New England Journal of Medicine (NEJM) reports that the use of Prevnar in infants and toddlers was associated with a significant reduction in invasive pneumococcal disease (IPD) in vaccinated children.
The study also demonstrated that the overall incidence of invasive disease caused by penicillin-resistant Streptococcus pneumoniae bacteria substantially declined since the vaccine's introduction.
Approved by the U.S. Food and Drug Administration (FDA) in February 2000, Prevnar remains the first and only vaccine approved to help prevent invasive pneumococcal disease in infants and toddlers. The routine vaccination schedule is 2, 4, 6, and 12-15 months of age.
The study, conducted by the Centers for Disease Control and Prevention (CDC), found a steep downward trend in the incidence of IPD in children under two years of age from the 1998 baseline period through 2001. "This study indicates that Prevnar is helping to prevent pneumococcal disease in young children," says Dr. Peter Paradiso, vice president of scientific affairs and research strategy. Surveillance showed a 78 percent decline in IPD in children under two caused by the strains targeted by the vaccine
"An important additional benefit is the reduction in disease events caused by penicillin-resistant strains," says Dr. Paradiso. Prevnar has also helped reduce disease caused by drug-resistant strains, a 35 percent disease reduction in IPD caused by strains that were not susceptible to penicillin among children under two years of age
"More than 42 million doses of Prevnar have been distributed nationwide and we have already seen a significant reduction in the incidence of potentially life-threatening invasive pneumococcal disease since its licensure," says Geno Germano, executive vice president and general manager of Wyeth Vaccines. "We are excited about the role that Prevnar has played in helping the CDC's "Healthy People 2010" initiative accomplish one of its objectives -- decreasing the incidence of IPD for children -- nine years ahead of schedule."
Prevnar is indicated for active immunization of infants and toddlers against invasive disease caused by S. pneumoniae due to the capsular serotypes included in the vaccine. The routine schedule is 4 doses, given at 2, 4, 6 and 12-15 months.
Risks are associated with all vaccines, including Prevnar. Hypersensitivity to any vaccine component, including diphtheria toxoid, is a contraindication to its use. Prevnar does not provide 100 percent protection against vaccine serotypes or protect against non-vaccine serotypes. See the Prescribing Information for indications and usage, dosage and administration, and safety information.
Source: Wyeth
Dear Helpdesk: Working in a Toxic Health Care Environment
March 28th 2024Dear Helpdesk is your steadfast companion, offering life coaching and workplace advice from 2 seasoned IPs for some of your most challenging real-life situations. Let us help you navigate the intersection between work and life, guiding you to navigate the dynamic world of infection prevention with confidence and grace. This article is on handling a toxic health care environment.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.